Recent years have seen a flood of studies linking genetic variations to particular diseases, and companies are trying to parlay those discoveries into direct-to-consumer genetic tests. Navigenics mails its subscribers containers for saliva samples. When it gets the samples back, it uses microarrays–chips studded with fragments of DNA–to screen the subscribers’ DNA for genetic variations linked to 18 diseases, including Alzheimer’s and colon cancer. Such genetic screening has received little clinical evaluation, however, so whether it helps prevent disease is unclear.
Credit: Joshua Scott
Product: Health Compass
Cost: $2,500 for the initial test; $250 a year for continued consultation
Other products in this section:
Keep up with the latest in DNA testing at EmTech MIT.
Discover where tech, business, and culture converge.
September 11-14, 2018
MIT Media Lab